Retatrutide is not yet FDA approved, but like many GLP-1 agonists such as Wegovy (semaglutide) and Mounjaro (tirzepatide), retatrutide will most likely be a weekly injection, delivered subcutaneously into the arm, thigh or stomach area in a self-inject pen
Clear and colorless This is the ideal appearance for pure tirzepatide, FDA-approved or compounded without B12
you need a system that makes adequate intake visible, trackable, and achievable without adding more pressure during this tough adjustment period
Some Medicaid plans may cover Wegovy, but eligibility requirements and coverage vary by state
Mutat Res Rev Mutat Res (2015) 763:21245
GLP-1 Injections change that and put weight loss within your control